GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » 5-Year Yield-on-Cost %

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) 5-Year Yield-on-Cost % : 0.00 (As of May. 05, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co 5-Year Yield-on-Cost %?

Beijing Bohui Innovation Biotechnology Group Co's yield on cost for the quarter that ended in Mar. 2025 was 0.00.


The historical rank and industry rank for Beijing Bohui Innovation Biotechnology Group Co's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Beijing Bohui Innovation Biotechnology Group Co's highest Yield on Cost was 0.30. The lowest was 0.03. And the median was 0.06.


SZSE:300318's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.71
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Beijing Bohui Innovation Biotechnology Group Co's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Beijing Bohui Innovation Biotechnology Group Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Bohui Innovation Biotechnology Group Co's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Bohui Innovation Biotechnology Group Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Beijing Bohui Innovation Biotechnology Group Co's 5-Year Yield-on-Cost % falls into.


;
;

Beijing Bohui Innovation Biotechnology Group Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Beijing Bohui Innovation Biotechnology Group Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Beijing Bohui Innovation Biotechnology Group Co  (SZSE:300318) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Beijing Bohui Innovation Biotechnology Group Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Bohui Innovation Biotechnology Group Co Business Description

Traded in Other Exchanges
N/A
Address
Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097
Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.
Executives
Niu Shu Hui Executives
Di Xiao Feng Director
Yang Qi Director
Lu Xin Qun Directors, executives
Zhang Lei Director
Wan Zhang Geng Executives
Song Rui Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines